A New Module in Neural Differentiation Control: Two MicroRNAs Upregulated by Retinoic Acid, miR-9 and-103, Target the Differentiation Inhibitor ID2

被引:53
作者
Annibali, Daniela [1 ]
Gioia, Ubaldo
Savino, Mauro [1 ]
Laneve, Pietro [1 ]
Caffarelli, Elisa [1 ,2 ]
Nasi, Sergio [1 ]
机构
[1] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol, CNR IBPM, Rome, Italy
[2] Univ Roma La Sapienza, Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy
来源
PLOS ONE | 2012年 / 7卷 / 07期
关键词
LOOP-HELIX PROTEINS; HUMAN NEUROBLASTOMA-CELLS; NEURONAL DIFFERENTIATION; RETINOBLASTOMA PROTEIN; CANCER METASTASIS; PROGENITOR CELLS; CODING REGIONS; IN-VIVO; EXPRESSION; RNA;
D O I
10.1371/journal.pone.0040269
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The transcription factor ID2 is an important repressor of neural differentiation strongly implicated in nervous system cancers. MicroRNAs (miRNAs) are increasingly involved in differentiation control and cancer development. Here we show that two miRNAs upregulated on differentiation of neuroblastoma cells - miR-9 and miR-103 - restrain ID2 expression by directly targeting the coding sequence and 39 untranslated region of the ID2 encoding messenger RNA, respectively. Notably, the two miRNAs show an inverse correlation with ID2 during neuroblastoma cell differentiation induced by retinoic acid. Overexpression of miR-9 and miR-103 in neuroblastoma cells reduces proliferation and promotes differentiation, as it was shown to occur upon ID2 inhibition. Conversely, an ID2 mutant that cannot be targeted by either miRNA prevents retinoic acid-induced differentiation more efficient than wild-type ID2. These findings reveal a new regulatory module involving two microRNAs upregulated during neural differentiation that directly target expression of the key differentiation inhibitor ID2, suggesting that its alteration may be involved in neural cancer development.
引用
收藏
页数:12
相关论文
共 66 条
  • [1] [Anonymous], NAT REV MOL CELL BIO
  • [2] Id sustains Hes1 expression to inhibit precocious neurogenesis by releasing negative autoregulation of Hes1
    Bai, Ge
    Sheng, Nengyin
    Xie, Zhihui
    Bian, Wei
    Yokota, Yoshifumi
    Benezra, Robert
    Kageyama, Ryoichiro
    Guillemot, Francois
    Jing, Naihe
    [J]. DEVELOPMENTAL CELL, 2007, 13 (02) : 283 - 297
  • [3] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [4] Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression
    Ben-Hamo, Rotem
    Efroni, Sol
    [J]. GENOME MEDICINE, 2011, 3
  • [5] BIEDLER JL, 1978, CANCER RES, V38, P3751
  • [6] 'Advanced' generation lentivirruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo
    Bonci, D
    Cittadini, A
    Latronico, MVG
    Borello, U
    Aycock, JK
    Drusco, A
    Innocenzi, A
    Follenzi, A
    Lavitrano, M
    Monti, MG
    RossJr, J
    Naldini, L
    Peschle, C
    Cossu, G
    Condorelli, G
    [J]. GENE THERAPY, 2003, 10 (08) : 630 - 636
  • [7] Neuroblastoma: Biological insights into a clinical enigma
    Brodeur, GM
    [J]. NATURE REVIEWS CANCER, 2003, 3 (03) : 203 - 216
  • [8] Id3 is a novel regulator of p27kip1 mRNA in early G1 phase and is required for cell-cycle progression
    Chassot, A-A
    Turchi, L.
    Virolle, T.
    Fitsialos, G.
    Batoz, M.
    Deckert, M.
    Dulic, V.
    Meneguzzi, G.
    Busca, R.
    Ponzio, G.
    [J]. ONCOGENE, 2007, 26 (39) : 5772 - 5783
  • [9] Targeting Id protein interactions by an engineered HLH domain induces human neuroblastoma cell differentiation
    Ciarapica, R.
    Annibali, D.
    Raimondi, L.
    Savino, M.
    Nasi, S.
    Rota, R.
    [J]. ONCOGENE, 2009, 28 (17) : 1881 - 1891
  • [10] CICCARONE V, 1989, CANCER RES, V49, P219